Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: a Southeastern Cancer Study Group trial. [electronic resource]
Producer: 19870427Description: 660-2 p. digitalISSN:- 0022-5347
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Transitional Cell -- drug therapy
- Cisplatin -- administration & dosage
- Clinical Trials as Topic
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Humans
- Male
- Middle Aged
- Prospective Studies
- Random Allocation
- Urinary Bladder Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.